TickerFactsScreenerDevelopers

FATE THERAPEUTICS INC (FATE) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2010: $11.22M2011: $6.39M2012: $9.09M2013: $54.04M2014: $49.10M2015: $64.81M2016: $88.61M2017: $88.95M2018: $190.51M2019: $99.81M2020: $167.35M2021: $133.58M2022: $61.33M2023: $41.87M2024: $36.06M2025: $46.63M$46.63M
2010Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$46.63M+29.3%
2024$36.06M-13.9%
2023$41.87M-31.7%
2022$61.33M-54.1%
2021$133.58M-20.2%
2020$167.35M+67.7%
2019$99.81M-47.6%
2018$190.51M+114.2%
2017$88.95M+0.4%
2016$88.61M+36.7%
2015$64.81M+32.0%
2014$49.10M-9.1%
2013$54.04M+494.7%
2012$9.09M+42.3%
2011$6.39M-43.1%
2010$11.22M—